Horizon Therapeutics Plc
(NASDAQ : HZNP)

( )
HZNP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 7.28%85.800.0%$544.17m
ICLRICON plc 0.00%246.552.8%$289.77m
VRXValeant Pharmaceuticals International, Inc. -7.05%27.5514.1%$162.11m
HZNPHorizon Therapeutics Plc 0.00%99.785.5%$111.96m
JAZZJazz Pharmaceuticals Plc 0.76%172.002.2%$87.65m
CTLTCatalent, Inc. -0.10%120.342.1%$78.43m
PRGOPerrigo Co. Plc -0.50%48.156.9%$49.48m
ENDPEndo International Plc 0.00%5.008.6%$46.33m
BHCBausch Health Cos., Inc. -7.05%27.550.0%$41.65m
ARGXargenx SE 0.00%308.760.0%$40.19m
UTHRUnited Therapeutics Corp. 0.00%179.8614.0%$38.81m
SAGESAGE Therapeutics, Inc. 1.45%44.007.6%$33.55m
NTECIntec Parent, Inc. 1.91%11.210.0%$32.38m
IRWDIronwood Pharmaceuticals, Inc. 0.00%13.279.6%$25.02m
AXSMAxsome Therapeutics, Inc. 1.85%51.251.9%$18.46m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.